After meningitis outbreak, insurers are reportedly reluctant to cover compounded medications
WGBH - 06/26/2017
“Insurance companies have really clamped down on the coverage of compounded medications,” said Todd Brown, a pharmacy professor at Northeastern University and executive director of the Massachusetts Independent Pharmacists Association.
Brown says the reduction in coverage came after the meningitis outbreak at the New England Compounding Center.
Brown says insurers saw the headlines and they saw other compounding pharmacies taking advantage of lax rules, so they tightened compounding coverage across the board.